RADIANT-3 Trial: Everolimus in Pancreatic Neuroendocrine Tumors
0 意见
• 07/08/23
0
0
嵌入
Jonathan Strosberg, MD, Diane Reidy-Lagunes, MD, MS, and Rodney F. Pommier, MD, discuss results from the phase III RADIANT-3 trial that explored everolimus in patients with pancreatic neuroendocrine tumors.
For more from this discussion, visit http://www.onclive.com/peer-ex....change/pancreatic-ne
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论